Sage Journals: Discover world-class research

Abstract

Chronic pain is highly prevalent and burdensome, affecting millions of people worldwide. Although it emerges at any point in life, it often manifests in adolescence. Given that adolescence is a unique developmental period, additional strains associated with persistent and often idiopathic pain lead to significant long-term consequences. While there is no singular cause for the chronification of pain, epigenetic modifications that lead to neural reorganization may underpin central sensitization and subsequent manifestation of pain hypersensitivity. Epigenetic processes are particularly active during the prenatal and early postnatal years. We demonstrate how exposure to various traumas, such as intimate partner violence while in utero or adverse childhood experiences, can significantly influence epigenetic regulation within the brain and in turn modify pain-related processes. We provide compelling evidence that the burden of chronic pain is likely initiated early in life, often being transmitted from mother to offspring. We also highlight two promising prophylactic strategies, oxytocin administration and probiotic use, that have the potential to attenuate the epigenetic consequences of early adversity. Overall, we advance understanding of the causal relationship between trauma and adolescent chronic pain by highlighting epigenetic mechanisms that underlie this transmission of risk, ultimately informing how to prevent this rising epidemic.

Keywords

fetal programming prenatal neonatal nociception sensitivity methylation microRNA intimate partner violence

Introduction

Epigenetics is an evolutionarily important phenomenon that regulates neurodevelopment and neuroplasticity in response to adapting environmental conditions (Mychasiuk 2015). Hence, epigenetics modulates the interplay between DNA and environmental conditions. There has recently been a shift toward understanding the role of early life experiences in neuropathologic processes, as they may prime individuals to be more susceptible to neurologic conditions such as chronic pain. Specifically, adverse early life experiences, including those that begin in utero, can modify the epigenome and phenotypic gene expression, potentially leading to changes in protein expression, proinflammatory cytokine activity (Elwenspoek and others 2017), hypothalamic-pituitary-adrenal (HPA) axis activity (Trollope and others 2012), and mechanisms of neuroplasticity (Salinas and others 2020). Chronic pain is a highly debilitating condition that affects a significant portion of adolescents, especially females, with prevalence estimated between 11% and 38% (King and others 2011). It is normally defined as persistent pain that endures for ≥3 months (Von Korff and Dunn 2008) and commonly presents with comorbidities such as anxiety and depression (Tunks and others 2008). While symptoms can arise at any time, adolescence is recognized as a period of high risk for chronic pain onset, with symptoms often being sustained throughout an individual’s life. Therefore, the purpose of this literature review was to integrate and assess current evidence regarding the role of epigenetics and early adversity in the development of chronic pain. Specifically, we examine literature regarding the influence of intimate partner violence (IPV) in utero and early life physical neglect on the development of chronic pain during adolescence. We provide current understanding of how epigenetic and environmental factors combine to propagate the intergenerational risk for chronic pain development, potential neurophysiologic mechanisms within the central nervous system that may be underlying this transmission, and gaps within the literature (mechanistic and epidemiologic) while highlighting potential prophylactic interventions that target epigenetic mechanisms. Particularly, we demonstrate that through epigenetic programming, perinatal trauma (an often-overlooked consideration for chronic pain origin) can potentiate the development of chronic pain.

Epigenetic Regulation of Gene Expression

Epigenetics represents the interplay between environmental factors and an individual’s genotype and involves specific molecular mechanisms that allow or inhibit gene expression in a temporal- and tissue-dependent manner (Mychasiuk 2015). These epigenetic regulations do not influence the primary nucleotide sequence but allow for adaption to selective environmental pressures, thereby conferring an immediate evolutionary advantage (Lind and Spagopoulou 2018). Epigenetic changes permit gene expression alterations between cells, which provides a foundation for cellular specialization in terms of morphology and functionality, resulting in a more adaptive organism (Mohn and Schübeler 2009; Wu and Sun 2006). Parental experiences, within the maternal and paternal lineages, significantly contribute to the offspring epigenome. Although the link between maternal experiences and child outcomes has long been established, the association between paternal experiences and epigenetic programming in offspring is a more recent discovery (Hehar and Mychasiuk 2015). Given the ongoing nature of spermatogenesis, as compared with oogenesis, the paternal environment bestows significant modulatory capacity on the offspring epigenome and subsequent development (Hehar and Mychasiuk 2015). Although not examined in the context of chronic pain, as the epigenomes from both parents combine during conception, we can infer that they are influencing risk and resiliency in this context. Given that epigenetic mechanisms can influence and regulate neuroplasticity (Mychasiuk 2015), they likely play a role in the cortical changes that underpin chronic pain neuropathology. The cell uses three key epigenetic mechanisms to regulate gene expression: DNA methylation, histone modification, and microribonucleic acids (microRNAs).

DNA Methylation

The most frequently studied epigenetic mechanism is DNA methylation, which involves the addition of a methyl group to the C₅ position of a cytosine nucleotide (commonly associated with a CpG island) to form a 5-methylcytosine (Moore and others 2013). DNA methylation is catalyzed by DNA methyltransferases (DNMTs), which are heavily involved in embryonic development and neuronal activity within the brain (Uysal and others 2015; Yin and others 2012). DNMTs are classified into one of three isoforms—DNMT1, DNMT3A, and DNMT3B—all of which catalyze the addition of the methyl group to the 5-carbon of the cytosine pyrimidine ring but under different contexts (Buchheit and others 2012). The addition of a methyl group to a CpG island inhibits active gene transcriptional factors from binding and results in silencing of gene expression (Denk and McMahon 2012). Alternatively, methylated CpG islands can bind to gene repressor factors such as MeCP2, which contain active repression domains resulting in suppression of gene expression (Nan and others 1997). DNMT3A and DNMT3B establish novel methylation patterns and hence are termed de novo DNMTs, while DNMT1 is responsible for replicating methylation patterns from parental to daughter chromosome strands during cell replication (Moore and others 2013). It is still not well understood how de novo methylation is acquired in terms of which genes are silenced and the mechanisms by which certain genes are silenced over others. One of the most popular current theories hypothesizes that the demethylation process is regulated by TET and TDG proteins. TET proteins induce or regulate the conversion of 5-methylcytosine to 5-hydroxymethylcytosine and then to 5-formylcytosine or 5-carboxylcytosine. TDG proteins are then able to excise the oxidized variations of cytosine formed by TET, at which point basic DNA repair mechanisms can restore an unmethylated cytosine nucleotide into the DNA strand (Wu and Zhang 2017). Moore and others (2013) proposed that there are multiple mechanisms for DNA methylation and demethylation that compensate for one another in varying circumstances. This suggests that DNA methylation is a vital component for adaptive gene expression as well as stable gene expression.

Histone Modifications

Histone proteins and nucleotide sequences form nucleosomes, which are the key foundations of chromatin (Mariño-Ramírez and others 2005). There are eight core histone proteins around which nucleotide sequences can wrap. The histone proteins are composed of a core globule section and a N-terminal tail that extends outward from the core, which other proteins and epigenetic factors can interact with (Biswas and others 2011). These interactions can result in acetylation, methylation, phosphorylation, or ubiquitination modifications, commonly to the lysine residues in the tail (Bannister and Kouzarides 2011). Depending on the type of histone modification, alterations to chromatic architecture result in more compacted or loosened strands, which ultimately influences the accessibility of transcriptional factors to the coding region of the gene (Turner 2000). Histone acetylation tends to cause the tightly bound chromatic to unwind, resulting in easier access for transcription factors; this is mediated by enzymes called histone acetyltransferases. Histone deacetylases (HDACs) do the opposite (Yang and Seto 2007). There are 4 classes of histone deacetylation enzymes, and they all play an important role in chromatin remodeling and regulation of gene expression (Mychasiuk 2015; Seto and Yoshida 2014). HDACs can interfere with and prevent removal of acetyl groups from histone proteins. HDACs form enzymatic complexes with corepressors that are regulated through protein-protein interactions (Seto and Yoshida 2014). As their primary function is the removal of acetyl groups, they play a significant role in genetic expression by providing access to binding sites on histones for transcription promoters or repressors (Seto and Yoshida 2014).

Elevated HDAC2 expression has been linked to changes in spine density, synaptic connectivity, and memory processes, suggesting that it plays a significant role in neuroplasticity (Guan and others 2009).

RNA Regulation

The last epigenetic mechanism of interest for this review is RNA regulation, which involves the activity of noncoding RNAs that regulate gene expression through recruitment of chromatin modulators, transcriptional repressors, and transcriptional activators or by complementary sequence binding to block translation (Mychasiuk 2015). MicroRNAs are regulatory mechanisms that usually result in gene silencing. This process involves binding of mRNA to small noncoding microRNA strands that subsequently block translation at the ribosome. MicroRNAs are capable of modifying spine morphology in hippocampal neurons (Schratt and others 2006), demonstrating that they can modulate plasticity through synaptic regulation. Similarly, noxious inflammatory stimuli induce changes in microRNA expression within the spinal cord, while knockdown of microRNA-124a increases proinflammatory markers in a mouse model (Kynast and others 2013).

Epigenetic Regulation during Prenatal Neurodevelopment

Fetal brain development is heavily regulated by epigenetic processes that produce unique gene expression patterns leading to cell specialization and functionality. Each cell contains the same genetic material; however, epigenetically regulated expression allows for differentiation as well as neurodevelopment and neurogenesis. DNA methylation mechanisms are initiated prior to implantation, whereby there is complete demethylation of the parental genomes (Howlett and Reik 1991), followed by de novo methylation as the embryo develops (Okano and others 1999). De novo DNA methylation plays a significant role in cell formation and is a major contributor to astrocyte formation (Fan and others 2005; Takizawa and others 2001) as well as formation of glia from neural stem cells (Nakagawa and others 2020). DNA methylation also regulates expression of genes such as Oct-4, which code for a transcription factor that is involved in repression of cell differentiation (Hattori and others 2004). Histone modifications are necessary for fetal neurodevelopment. Studies investigating HDAC1 activity in mouse models found that it was vital for cell differentiation through repression of growth-inhibitory factors (Lagger and others 2002; Zupkovitz and others 2006). Similarly, disruption of histone methylation via the enzyme G9a led to embryo death in a mouse model (Tachibana and others 2002; Takizawa and others 2001). There is less literature on RNA regulatory mechanisms, although small noncoding RNAs are able to cross the murine placental barrier and can be measured within the fetus; therefore, they likely influence gene expression and neurodevelopment (Li and others 2015). Finally, epigenetics likely contributes to the development of sex differences, which begin later in fetal development (Scott and others 2011). While there are still many unknowns, epigenetic regulation is pivotal for development of the CNS and cell proliferation. As such, environmental factors associated with maternal health may lead to alterations within the fetal epigenome and subsequent development, which prime the body for the manifestation of chronic pain during postnatal life.

Fetal Programming, Epigenetics, and the Maternal Environment

As epigenetic regulation is highly prevalent during prenatal development, the intrauterine environment is incredibly important for establishing the fetal epigenome. The interplay between the epigenome and the intrauterine environment is known as fetal programming, whereby maternal factors influence developmental trajectories of the offspring by priming the fetus for certain environmental conditions (Hocher 2014). Fetal programming is an evolutionarily beneficial process as it allows for rapid adaptation, opposed to slower-acting mendelian inheritance. Fetal programming represents a situation where the fetus “gambles” that its future environment will resemble its in utero experience. However, in cases where there is a mismatch between the in utero environment and the conditions of postnatal development, this gamble can result in health complications and a predisposition for many noncommunicable illnesses, such as coronary heart disease, liver problems, and neuropsychiatric disorders (Godfrey and Barker 2001; Figure 1).

Figure 1.

Maternal factors and the timeline whereby they lead to health complications in subsequent generations. As there are various maternal factors capable of modifying fetal epigenetic profiles, a known mismatch between prenatal and postnatal environment influences many health benefits or complications during adolescence and adulthood. HPA = hypothalamic-pituitary-adrenal.

The majority of fetal programming research has been conducted within the context of maternal malnourishment and insulin resistance in offspring (Hocher 2014). These studies have demonstrated that maternal malnourishment during pregnancy alters offspring gene expression, which leads to alterations in metabolic homeostasis that prepare the fetus for caloric deficits during postnatal life (Gicquel and others 2008). However, when there is a surplus of calories during infancy and adolescence and into adulthood, these fetal-induced alterations to the metabolic phenotype can lead to insulin resistance and diabetes (Zhu and others 2019). More recently, scientific literature has explored maternal stress and its influence on fetal programming and the epigenome (Mychasiuk and others 2011). Li and others (2012) showed that maternal cortisol levels were inversely proportional to the growth of the fetal brain. Moreover, current literature indicates that elevated maternal cortisol can influence the development of the HPA axis during gestation (Irwin and others 2021). As maternal cortisol crosses the placental barrier and reaches the developing fetus, the placenta has evolved to prevent excess maternal cortisol from influencing development. The enzyme 11β-HSD2 (11β-hydroxysteroid dehydrogenase type 2) oxidizes cortisol to its biologically inactive form cortisone to prevent it from negatively interacting with the developing fetus (Brown and others 1996). Yet, in cases of elevated maternal cortisol levels, enzymatic activity in the placenta is saturated, which results in active cortisol flooding the intrauterine environment. These cortisol levels are often toxic to the developing fetus, altering development of the fetal brain. Specifically, excessive cortisol can modulate maturation and migration of inhibitory GABAergic neurons, which are important for establishing the cortical structure during fetal neurodevelopment (Fine and others 2014). Additionally, maternal anxiety and proinflammatory cytokine activity may down-regulate 11β-HSD2 activity (Kossintseva and others 2006; O’Donnell and others 2012), further increasing the levels of maternal cortisol that cross the placenta.

Moreover, studies have demonstrated that elevated maternal immune activity may alter epigenetic mechanisms (Basil and others 2014; Han and others 2021; Labouesse and others 2015). For example, maternal immune activation was able to induce hypomethylation of the MeCP2 gene within the hypothalamus in adolescent mice (Basil and others 2014). Changes in MeCP2 activity have been linked to changes in dopaminergic neuronal branching and neural connectivity (Gantz and others 2011). Reduced activity of dopaminergic neurons has been associated with reduced analgesic effects (Wood and others 2007), although demonstrating that these three mechanisms drive the chronification of pain has not transpired to date. In addition, maternal immune activity has been linked to reduced expression of GAD1 and GAD2 in the prefrontal cortex (PFC) of offspring in a murine model (Labouesse and others 2015). As such, it is evident that maternal factors can produce changes in offspring health by modulating epigenetic activity.

It is important to note that maternal influences on the epigenome and subsequent neurodevelopment of offspring likely occur in a sex-dependent manner (Bale 2011), which may underpin the physiologic differences associated with higher rates of chronic pain in females (Mychasiuk and others 2011). Elevated levels of maternal and placental cortisol during pregnancy influence male and female fetuses differently (Sandman and others 2013). In males but not females, neuromuscular and cognitive abnormalities are often observed throughout gestation and postnatal year 1 (Sandman and others 2013). Temperamental and affective abnormalities were observed in females who were exposed to elevated maternal cortisol at 2 years of age, and reduced brain volume was observed in female youth aged 6 to 9 years (Buss and others 2011). Additionally, elevated maternal cortisol enlarged the right amygdala in females at ~7 years of age but not in males (Buss and others 2012). While this study did not investigate these parameters in relation to chronic pain, changes in brain anatomy, cognition, and affective behaviors are hallmark features of chronic pain, suggesting that fetal programming may be related to a predisposition to chronic pain in a sex-dependent manner. As such, maternal health influences the intrauterine environment and neurodevelopment and so should be considered a risk factor for the development of chronic pain.

IPV during Pregnancy

IPV is an unfortunately common form of abuse that affects women daily on a global scale (Chibber and Krishnan 2011; Mojahed and others 2021) and frequently arises or escalates in severity during pregnancy (Campo 2015). Globally, ~27% of women aged 15 to 49 years have experienced physical or sexual abuse or both from their partners (Sardinha and others 2022), and based on an American study, 6.1% of women were abused during pregnancy (Martin and others 2001). Given that many women never report their abuse or inform authorities, this statistic is likely a conservative estimate (Gracia 2004). The literature regarding the health of women who have experienced IPV is scarce and even lacking for women who were pregnant at the time of IPV. This is partially due to the nature of IPV, as women often endanger themselves by indulging this information or participating in research (Hellmuth and Leonard 2013). As such, animal models are necessary to clarify neuropathologic and behavioral outcomes related to IPV. However, there are currently very few robust and clinically relevant preclinical models, especially when considering the scale of the problem. There are also problems with existing definitions of IPV and violence against women. The definition has purposefully been kept broad and includes financial, physical, and sexual abuse, as well as emotional manipulation, coercion, and threats against women (United Nations 1993). This broad definition highlights the nuance of the issue, as well as the scale of gender-based violence that can occur in public or private, but it results in incomplete data regarding the specific consequences of physical abuse (Ruiz-Pérez and others 2007). All forms of abuse can have severe long-term consequences, yet for clarity of this review, we focus primarily on physical abuse in pregnant women.

Pregnancy involves significant physiologic and anatomic changes to the women’s body: elevated cardiac output, decreased oxygen reserves, elevated stress hormones, and other metabolic changes that are required to meet the demands of a developing fetus (Tan and Tan 2013). The added health complications associated with physical abuse can put the mother and fetus in physiologically dangerous situations (Donovan and others 2016). The physical abuse that pregnant women endure can vary quite significantly in terms of the type of abuse and the severity. However, head and neck injuries are the most common forms of physical abuse sustained, with 40% of participants who experienced physical abuse presenting injuries in these regions (Bhandari and others 2006). Physical abuse often involves trauma to the brain via direct impact to the skull and/or through hypoxia-induced strangulation (Monahan and others 2022). These injuries are rarely sustained in isolation, with most women experiencing strangulation in addition to multiple types of blunt force trauma (Shields and others 2010). Women who have sustained a traumatic brain injury are more likely to have long-term CNS complications as compared with abused women who do not sustain a traumatic brain injury (Campbell and others 2018). As such, IPV is a large-scale tragedy that affects the lives of millions of women and may in turn affect subsequent generations through fetal programming.

The majority of adverse outcomes investigated in infants exposed to IPV while in utero have focused on short-term outcomes and include low birth weight, preterm labor, and perinatal death (Donovan and others 2016; Figure 2). To our knowledge, only one study has investigated the influence of traumatic brain injury during pregnancy, which established increased depressive behaviors in the offspring. Beyond this, there is very limited information (Saber and others 2021)

Figure 2.

Overview of basic health complications associated with intimate partner violence. STI = sexually transmitted infection.

Women who experience IPV during pregnancy are three times more likely to have perinatal death than pregnant women who do not experience IPV, although this can be partially rectified through IPV screening at pregnancy clinics and inclusion of appropriate medical support throughout pregnancy (Pastor-Moreno and others 2020). Although there is an abundance of research on fetal programming linked to prenatal stress, such as neurologic changes, mental illness, inflammatory factors, and increased rates of substance use, to our knowledge only one study has examined these outcomes in the context of prenatal IPV, which determined that such infants are at an increased risk of neurologic delay (Udo and others 2016). The long-term implications of intergenerational trauma have been established in the offspring of genocide survivors, war veterans, and famine sufferers (Matz and others 2015; Yehuda and Lehrner 2018). However, an important gap in the literature still exists within the context of noncortisol-induced endocrine and neuroplastic changes in the developing fetus. For example, Radtke and others (2011) found increased methylation of the glucocorticoid receptor (GR) in the offspring of victims of IPV, although this study included a broad definition of abuse that was not limited to physical. Unfortunately, Radtke’s study is the only identified literature investigating epigenetic changes in the offspring of IPV victims. Changes in GR expression may alter HPA activity and produce changes in the stress response of the offspring later in life (Meaney and others 2007; Mychasiuk and others 2011). Based on current literature demonstrating that the intrauterine environment is important for influencing neurodevelopment, it is worth assessing IPV as a potential contributor to epigenetic regulation of gene expression and subsequent chronic pain in offspring.

Epigenetics and Early Life Neurodevelopment during Infancy

The human brain continues to mature through childhood, adolescence, and early adulthood, and epigenetic mechanisms influence these developmental processes. The first few years of life represent a period of rapid growth in myelination, functional connectivity, and cortical gray matter development (Gilmore and others 2018; Knickmeyer and others 2008). Sexual dimorphisms also become more apparent during early development with noted differences in regional volumetric measures. For example, Knickmeyer and others (2014) found that females have larger dorsolateral PFCs, a region implicated in chronic pain development. While prenatal brain development is characterized largely by proliferation, migration, and specialization, postnatal/early childhood neurodevelopment is largely driven by synaptogenesis and synaptic pruning, resulting in more efficient and plastic neural networks (Tierney and Nelson 2009). The generation of efficient neural networks involves activity-dependent synaptic strengthening referred to as long-term potentiation (Madison and others 1991). A study conducted in Aplysia demonstrated that histone acetylation and chromatic remodeling are involved in synaptic plasticity (Guan and others 2002), suggesting that they are relevant mechanisms for long-term potentiation throughout childhood. Other relevant genes involved in neuroplastic processes, such as dendritic branching and neural connectivity, include brain-derived neurotrophic factor (BDNF; Bathina and Das 2015), which requires phosphorylation of MeCP2 to drive up-regulated expression and consequently increased branching within a mouse model (Zhou and others 2006). As such, epigenetic mechanisms dictate neural connectivity and may mediate neural network changes that predispose individuals to heightened pain sensitivity during adolescence and adulthood, including changes in mesocorticolimbic communication. In Table 1 we provide a brief summary of selected genes that may undergo epigenetic modulation following perinatal trauma and subsequently lead to increased risk for the development of chronic pain. Although more research is needed to identify additional genes of interest and determine if there is a causal relationship between them and chronic pain, their ability to act across circumstances highlights their potential importance and need for further investigation.

Table 1.

Selection of Genes That May Be Involved in the Epigenetic Transmission of Risk for Chronic Pain Following Pre- and Postnatal Trauma and Onset of Chronic Pain.

Gene Name	Primary Function	Role in Prenatal Trauma	Role in ACEs	Role in Chronic Pain
BDNF (brain-derived neurotrophic factor)	Neurotrophic growth factor involved in development and neuroplasticity (Miranda and others 2019)	BDNF was reduced in pregnant females with PTSD and depression (Yang and others 2016). Limited evidence on IPV or specific mechanisms of epigenetic regulation.	Preclinical model of early life maltreatment persistently increased methylation of the BDNF exon IX (Roth and others 2009).	BDNF minimally involved in acute pain but prominently in the chronification of pain in a BDNF knockout mouse (Sikandar and others 2018).
NR3C1/GR	Encodes the glucocorticoid receptor; role in HPA axis activity (NCBI 2022).	Maternal prenatal stress increased methylation of NR3C1 and increased expression of NR3C1 within the placenta (Capron and others 2018). Meta-analysis demonstrated relationship between maternal stress and methylation profiles of NR3C1 in offspring (Palma-Gudiel and others 2015).	Altered methylation of NR3C1 gene in survivors of childhood abuse (McGowan and others 2009). Childhood trauma, including physical neglect, increased methylation of NR3C1 (Perroud and others 2011).	Increased methylation of NRC31 in a rodent model of chronic stress–related pain hypersensitivity (Hong and others 2015).
MeCP2	Involved in chromatin remodeling (MedlinePlus Genetics 2022).	Increased maternal immune activity in mice reduced methylation levels of the MeCP2 gene (Basil and others 2014).	None	Increased expression of MeCP2 in a model of intergenerational chronic pain (Tao and others 2020).
TNF-a	Encodes a proinflammatory cytokine (PubChem 2022b).	Prenatal stress increased TNF-a expression in the frontal cortex of offspring (Szczesny and others 2014).	Children with a history of trauma exhibit increased expression of TNF-a (Bücker and others 2015).	TNF-a increased in female rats following chronic constriction injury of the sciatic nerve (Schäfers and others 2003). Increased TNF-a levels in the hippocampus postinjury in male rats (Ignatowski and others 1999).
Dopaminergic system encompassing DRD2, COMT, and MAOA	Regulates neurotransmission important in mediating reward and motivation responses.	Prenatal stress increased DR-2 receptor expression (Berger and others 2002).	Maternal separation decreased dopamine receptors in the PFC (Rentesi and others 2013). In mice, no association between MAOA methylation in the brain and early life adversity (Mattern and others 2019).	DNA methylation increased COMT in patients with fibromyalgia and chronic fatigue (Polli and others 2022).
FKBP51	Prominent role in regulation of the HPA axis, glucose tolerance (Hähle and others 2019), and protein trafficking (PubChem 2022a).	Prenatal stress resulted in persistent hypermethylation of three regions of FKBP51 in the left dorsal hippocampus (Plank and others 2021).	Physical abuse resulted in hypomethylation of the FKBP51 gene that was dependent on individual allele type (Klengel and others 2013).	No current evidence of epigenetic regulation of FKBP51 in chronic pain, although it does play a role (Maiarù and others 2016).

ACE = adverse childhood experience; HPA = hypothalamic-pituitary-adrenal; IPV = intimate partner violence; PFC = prefrontal cortex; PTSD = posttraumatic stress disorder.

Adverse Childhood Experiences

Adverse childhood experiences (ACEs) are potentially traumatic experiences that can have lifelong influences on psychological, social, and physical well-being (Boullier and Blair 2018). ACEs have been implicated in a variety of diseases and negative health outcomes (Felitti and others 1998; Kalmakis and Chandler 2015). Chronic pain is more prevalent in individuals exposed to ACEs as compared with the general population (Groenewald and others 2020). Furthermore, current trends suggest that women experience ACEs at a higher rate than males (Haahr-Pedersen and others 2020), which may correspond to the sex differences noted in patients with chronic pain (King and others 2011). Similar to patterns of IPV, ACEs tend to be more common in populations characterized by lower socioeconomic status and financial instability (Walsh and others 2019). As implied by their definition, ACEs occur during early childhood, which is when the PFC, amygdala, and hippocampus are still particularly plastic and sensitive to external influences. As a result, ACEs exercise great influence over development of the CNS and formation of neural networks.

ACEs are commonly assessed and quantified with the ACE questionnaire (World Health Organization 2020), which focuses on childhood experiences related to maltreatment (physical or sexual abuse, physical neglect) or household dysfunction (being witness to violence, drugs, or prison time of a relative; Boullier and Blair 2018). More recent literature has highlighted the impact of social and economic traumatic events that occur during childhood, such as poverty, peer victimization, and bullying, as these early experiences have demonstrated an influence on long-term physical and mental health (Finkelhor and others 2015).

Physical neglect is an ACE characterized by failure of the parents or caregivers to properly care for their children, including failing to feed, clothe, protect, or manage their health requirements (Boullier and Blair 2018). The ACE of physical neglect is also associated with the development of chronic pain later in life (Davis and others 2005). Importantly, physical neglect can be recapitulated in preclinical studies with the use of the maternal separation paradigm, whereby pups are removed and isolated from their mother during the first 2 weeks of development (Vetulani 2013). This is a critical period of brain development, wherein sensory and nociceptive pathways are still maturing (Bâ and Seri 1993). Preclinical studies demonstrate that maternal separation alters development of the HPA axis (Aisa and others 2007) and nociception. Maternal separation has been associated with increased H3 histone acetylation and decreased methylation within the promoter region of the corticotrophin-releasing hormone gene (CRH; Wang and others 2014). Although this study did not examine nociceptive outcomes, it did show that early life trauma influences neuroendocrine functions and gene expression within the CNS. Similar findings have been replicated in human childhood abuse survivors who exhibit decreased levels of glucocorticoid receptor mRNA due to methylation changes on the NR3C1 gene, when quantified in adulthood (McGowan and others 2009). Glucocorticoid receptors have also been implicated in mouse models, with changes in acetylation being linked to maternal behaviors such as grooming and arched-back nursing (Weaver and others 2004). Clinical research has demonstrated that neglect can induce increased activity within the amygdala and lead to changes in a child’s ability to register affective and social cues (Tottenham and others 2011). Increased amygdala activity has also been noted in models of chronic pain (Neugebauer and others 2004). As such, changes in neuronal activity within the amygdala after physical neglect induce functional and structural transitions that may underpin the development of persistent pain. However, it is important to note that many of the negative effects associated with ACEs are ameliorated when resiliency factors are present. Particularly in the context of intergenerational transmission of chronic pain, studies have shown that positive coping strategies, supportive social groups, and elevated socioeconomic status can buffer the negative consequences of ACEs (Beveridge and others 2022; Chang and others 2022; Nimbley and others 2023). Therefore, although early life experiences do modify development of the neural circuitry related to persistent pain via epigenetic regulation of gene expression, this does not always occur in a negative fashion. In Figure 3, we highlight a subset of the consequences associated with IPV and ACEs.

Figure 3.

An infographic detailing statistics relevant for IPV (García-Moreno and others 2005; World Health Organization 2021) and ACEs (Boullier and Blair 2018; World Health Organization 2022) based on data collected from the World Health Organization. ACE = adverse childhood experience; IPV = intimate partner violence.

An Overview of Chronic Pain and the Underlying Neuropathology

Prevalence and Epidemiology in Adolescence

Chronic pain is a complex and multidimensional disease characterized by nociceptive, cognitive, affective, and behavioral changes. It is recognized as one of the most burdensome diseases globally and represents a significant disruption in quality of life (Blyth and others 2001). While the use of animal modeling precludes our ability to understand the subjective and affective components of pain, it does allow for targeted investigations into neurologic mechanisms that drive changes in nociception and the transition and manifestation of chronic pain pathology. Pain in rodents is typically assessed through observation of paw withdrawal following exposure to a mechanical or thermal stimulus. As such, preclinical assessment of pain is primarily dependent on nociceptive responsivity and does not often recapitulate the emotional and experience-dependent components of human-specific pain. Therefore, while rodent pain models lack components of persistent pain symptomology typically observed clinical populations, they do allow for invasive neurophysiologic assessment of the mechanistic processes involved in epigenetically derived nociceptive changes. Chronic pain is generally defined as a form of persistent pain that lasts for 3 months, as measured over a 6-month period (Treede and others 2015). It is also characterized by the experience of allodynia, the experience of pain in response to an innocuous stimulus, and/or hyperalgesia, the experience of an exacerbated pain response following exposure to a noxious stimulus (Jensen and Finnerup 2014). Although chronic pain may arise in response to an initial injury, it is frequently idiopathic, presenting with no defined origin.

Although some factors may increase the likelihood of developing chronic pain, it is a heterogenous and complicated disease that typically manifests in adolescence. Alarmingly, the development of chronic pain during adolescence often predisposes an individual to chronic pain throughout adulthood, which has significant implications for overall quality of life (Hadi and others 2019). The PFC is one of the brain regions with the greatest capacity for neuroplastic change during adolescence. Sensory and motor neural cortices tend to develop earlier, while regions that are involved in cognitive, social, and judgment-based decisions develop later (e.g., the PFC; Arain and others 2013). The functional and physiologic mechanisms with the greatest plasticity in the adolescent brain likely confer evolutionary benefit by allowing them to engage more readily and independently with their environment. However, this sensitivity to environmental factors increases risk and susceptibility to a plethora of illnesses, such as depression and anxiety (Kessler and others 2007; Paus and others 2008). As such, adolescence represents a significant window of sensitivity for which an individual is susceptible to positive and negative experiences.

Mesocorticolimbic System in Chronic Pain

The mesocorticolimbic system includes several functionally distinct regions—such as the PFC, amygdala, nucleus accumbens (NAc), ventral tegmentum, and hippocampus—and is implicated in pain as well functions related to higher-order thinking, memory, and affective response (Vachon-Presseau and others 2016). The amygdala and PFC are involved in the acute pain response, as they integrate emotional information and incoming afferent information regarding painful stimulus (Ong and others 2019). Interestingly, in a human study assessing changes in gray matter volume with voxel-based morphometry, individuals with chronic lower back pain exhibited global decreases in gray matter volume that exceeded age-expected changes, with noticeable decreases in the dorsolateral PFC (Apkarian and others 2004). However, although patients were age and sex matched, the authors did not disclose whether the participants were undergoing pharmacologic treatment, which may have influenced the brain changes that they identified. That being said, numerous studies investigating patients with migraine (Schmidt-Wilcke and others 2005), complex regional pain disorder (Geha and others 2008), and fibromyalgia (Kuchinad and others 2007) also identified changes in gray matter volume. Although the mechanisms underlying the changes to gray matter cannot be elucidated in clinical cohorts, rodent studies demonstrate that these changes may be due to alterations in dendritic morphology (Kang and others 2019), thereby suggesting that chronic pain reorganizes gray matter architecture within the brain. Moreover, glutamate levels in the PFC of rodents and humans with chronic pain are reduced, indicating that excitatory signaling is distorted, which may subsequently result in negative emotional and cognitive outcomes (Kelly and others 2016; Naylor and others 2019). Similarly, activation of GABAergic inhibitory neurons within the prelimbic region, a substructure of the rodent PFC that is similar to the ventromedial PFC in terms of function, is significantly reduced in models of pain (Zhang and others 2015). Taken together, these findings suggest that chronic pain is associated with modulation to excitatory and inhibitory neurotransmission within the PFC.

As the PFC of adolescents is undergoing significant maturation, modulation at the neurotransmitter level and/or neural connectivity can happen quite readily and has the potential to induce persistent, long-term changes. In alignment with this, changes to the connectivity and communication among the PFC, amygdala, and NAc may be important for the transition from acute to chronic pain (Baliki and others 2011). Chronic pain includes its own centrally driven pain response that differs mechanistically from the acute pain response. Patients with chronic lower back pain demonstrated increased white matter connectivity among the PFC, amygdala, and NAc over a 3-year testing period (Baliki and others 2012). It has been suggested that the functional expansion between the NAc and PFC results from an increase in emotional salience, although how this relates to the chronification of pain is less well understood (Vachon-Presseau and others 2016). Increased activity within the PFC, amygdala, and NAc may result in amplification of a pain responses via integration of nociceptive information with emotional salience (Vachon-Presseau and others 2016). Alternatively, these changes in connectivity may interfere with dopaminergic signaling and other neurotransmitter activity, resulting in altered synaptic and neural communications, reorganization of neural networks, and distorted nociceptive inputs.

Evidence from fMRI data has implicated the PFC in chronic pain. Interhemispheric connectivity between the left and right dorsolateral PFC was important in analgesia and intensity of pain responses (Sevel and others 2016), while a study by Youssef and others (2014) demonstrated that cerebral blood flow increased within the dorsolateral PFC of patients with chronic pain. Increased cerebral blood flow may be indicative of increased activity in the dorsolateral PFC, suggesting that this brain region is attempting to control or suppress the ongoing nociceptive input. Alternatively, the activity in the dorsolateral PFC may be modulating behavioral and affective outcomes, such as those associated with catastrophizing beliefs, which are common in individuals with chronic pain (Gracely and others 2004). Unfortunately, while it is well understood that modifications to the corticolimbic and mesocorticolimbic systems underpin chronic pain pathology, how they translate into altered nociceptive input is still poorly understood. Furthermore, additional investigation is necessary into the underlying mechanisms that regulate changes in plasticity and neural connectivity to produce large-scale cortical reorganization observed in patients with chronic pain.

A Complicated Relationship: Epigenetics, Trauma, and the Development of Chronic Pain

Current literature demonstrates that trauma influences epigenetic processes that may predispose individuals to chronic health conditions. Although our existing knowledge of the epigenetic mechanisms driving changes in chronic pain risk is still emerging, it is becoming clear that early life experiences play a significant role. In what follows, we highlight a few studies that have investigated the role of epigenetics on chronic pain.

DNA methylation studies have demonstrated changes in the methylome following neuropathic injury at chronic time points (Massart and others 2016; Tajerian and others 2013). These studies have identified chronic alterations in DNA methylation patterns systemically with changes present in T cells (Massart and others 2016) and within the spinal cord (Tajerian and others 2013), suggesting that DNA methylation aids in peripheral and central sensitization. For example, methylation changes were observed in opioid, glutamate, and dopamine receptor genes, all of which have been linked to modifications in pain thresholds (Massart and others 2016). Alterations in methylation profiles have also been highlighted in human populations with higher exposure to early life adversity (Wiegand and others 2021). However, whether these changes are contributing to changes in nociception is still poorly understood, and we can therefore only infer correlational associations and not causal relationships. Additionally, Garriga and others (2018) reported that methylation patterns differ in a temporal- and regional-dependent manner following spinal nerve ligation in rodents. At an acute time point, methylation levels increased, yet at subacute and chronic time points, methylation within the dorsal root ganglion (DRG) decreased while hypermethylation was observed in spinal cord and PFC (Garriga and others 2018). These studies showed that although methylation patterns change across time and region of interest, they may contribute to changes in CNS pain sensitivity. See Figure 4 for potential mechanisms of epigenetic regulation of chronic pain development and sensitization. Furthermore, a rodent study demonstrated that methylation patterns undergo remodeling in the peripheral nervous system and DRG following nerve injury (Gölzenleuchter and others 2015), corroborating the hypotheses that epigenetic processes that may drive persistent pain phenotypes. The DRG is a key relay station for nociceptive information between the peripheral and central nervous systems and, as such, plays a substantial role in the chronification of pain. For example, hyperexcitation in the DRG significantly contributes to sensitization in neuropathic pain, and while the specific mechanisms are still under investigation, animal models suggest that up-regulation of DNMT gene expression occurs within the DRG following spared nerve injury (Pollema-Mays and others 2014).

Figure 4.

Simplified schematic detailing the basic processes whereby epigenetic regulatory factors may influence gene expression and chronic pain development. Within peripheral nerves (top panel), changes to methylation levels may increase protein expression, resulting in increased receptor density in nociceptors or cytokine secretion by immune cells. In the dorsal root ganglion of the spinal cord (left panel), histone deacetylation induced through physiologic changes can lead to increased pain sensations. Additionally, RNA regulation within the brain (right panel) may inhibit expression of dendritic inhibitory factors resulting in increased branching among the prefrontal cortex (PFC), amygdala, and nucleus accumbens (NAc).

Additionally, DNA methylation contributes to the systemic aspects of chronic pain by influencing expression of proinflammatory cytokine levels. For example, methylation patterns were examined in patients with short- and long-term persistent lower back pain (6 weeks and 6 months). Individuals with long-term persistent pain had lower overall levels of DNA methylation and higher levels of mRNA expression for proinflammatory cytokines such as IL-2 (Eller and others 2021). Similarly, chronic nonspecific lower back pain was associated with changes in overall methylation patterns and hypomethylation of immune-related genes (Aroke and others 2020). Taken together, these results suggest that DNA methylation may influence the development of inflammatory and neuropathic-related pathology in chronic pain conditions. Surprisingly, a meta-analysis investigating the relationship between early life trauma and circulating markers of inflammation in adolescents concluded that associations between early life adversity and inflammatory markers were quite small (Kuhlman and others 2020). However, the study was limited in that it assessed only two inflammatory markers (IL-6 and C-reactive protein), of which C-reactive protein alone demonstrated significant change. As such, it is currently challenging to generate robust conclusions regarding the mechanisms driving the associations among inflammation, early life trauma, and chronic pain as there is a scarcity of literature.

Additionally, Hobo and others (2011) found that the administration of an HDAC inhibitor, valproate, increased expression of multiple glutamate transporters within the spinal dorsal horn, leading to decreased sensitivity following spinal nerve ligation. Central sensitization of the spinal cord and increased long-term potentiation are important steps in hypersensitive responses to noxious or, in some cases, innocuous stimuli (Ji and others 2003). As such, acetylation patterns, HDACs, and HDAC inhibitors likely play important roles in chronic pain–associated neuroplasticity (Levenson and others 2004). HDACs have also been linked to changes in expression of glutamic acid decarboxylase (GAD65), an enzyme necessary for the synthesis of GABA. Administration of HDAC inhibitors to wild type mice induced an increase in GAD65 expression, improved GABA synaptic functions, and resulted in mice with higher baseline thresholds of pain (Zhang and others 2011). Similar to other epigenetic processes, histone modifications independently regulate each gene separately, in a spatially and temporally independent manner. Beyond neuroplasticity, histone acetylation patterns modulate immune factors to prolong the inflammation often associated with chronic pain. Inflammatory mediators such as Nf-kB are heavily regulated via epigenetic mechanisms; in turn, proinflammatory mediators such as IL-1β (Ito and others 2000) and TNF-α (Rahman and others 2002) promote hyperacetylation of inflammatory promoter regions. As the immune system plays a significant role in pain sensitization whereby immune factors exacerbate hyperexcitability in nociceptors (Marchand and others 2005), it is possible that histone modifications are involved in sensitization processes in the peripheral and central nervous systems via regulation of neuroimmune properties. However, current understanding of histone modifications in the transition of acute to chronic pain is poorly understood, and further research is needed to establish the specific mechanisms driving this relationship. Based on their larger roles in synaptic regulation and cortical development, histone modifications may be regulating cortical reorganization within the CNS following exposure to perintatal trauma, thereby driving subsequent chronic pain development.

Finally, there is evidence that RNA regulation and microRNAs modulate the transition from acute to chronic pain in the context of perinatal trauma. Unique microRNA profiles have been identified in victims of childhood trauma with specific changes in expression of let-7g-5p, miR-103a-3p, miR-107, and miR-142-3p, which are associated with neurodevelopment and depression (Van der Auwera 2019). However, this study did not assess nociceptive outcomes. Although these changes in microRNA profiles are relevant to chronic pain development and early life trauma, they were not examined in a manner that would permit associative comparisons.

In addition to early life trauma, patients with persistent migraines exhibit altered microRNA profiles, including up-regulation in miR-27B and down-regulation in expression of miR-181a, let-7B, and miR-22 (Tafuri and others 2015), suggesting that pathologic pain may involve unique expression of regulatory RNA. MicroRNA changes within cerebrospinal fluid have also been linked to the pain associated with fibromyalgia (Bjersing and others 2013).

Beyond the scope of pain pathology, microRNAs represent a viable method of treatment. Single microRNA sequences can modify the expression of multiple genes, which is beneficial in treating complex conditions such as chronic pain that involve gene expression modifications across multiple tissues and genes. For example, when microRNA-124 was up-regulated in female mice with spared nerve injury–induced neuropathic pain, their pain response was normalized and their mechanical allodynia inhibited (Willemen and others 2012). Despite this, there are currently no microRNA interventions that have progressed to large-scale clinical trials focused on chronic pain (López-González and others 2017). Nevertheless, future studies should continue to explore this avenue, as epigenetics and early life trauma likely play a significant role in the onset and development of chronic pain during adolescence.

Prophylactic Treatments for Chronic Pain

There are currently numerous analgesics available for chronic pain. These include medications such as opioids, antidepressants, nonsteroidal anti-inflammatory drugs, and other anti-inflammatory drugs. While many of these have demonstrated efficacy for pain symptoms in the short term (Ballantyne and Shin 2008; Payne 2000), they often lead to adverse reactions and tolerance, both of which reduce their long-term feasibility (Dumas and Pollack 2008). As such, increased efficacy and treatment options are required to address chronic pain symptoms.

There are currently very few pharmacologic agents that target the deficits and impairments associated with in utero trauma and ACEs. One treatment worth investigating, however, is oxytocin. Colloquially known as the “love hormone,” oxytocin is a neuropeptide produced by the posterior pituitary hypothalamus (Blanks and Thornton 2003). Oxytocin is a key hormone in parturition and lactation (Blanks and Thornton 2003; World Health Organization 2009) that has more recently been linked to prosocial behaviors and socialization (Marsh and others 2021). Oxytocin is commonly used as a pharmacologic agent during pregnancy to assist with increasing uterine contractions resulting in quicker labor processes (Bugg and others 2013). The hormone has also been implicated in metabolic and homeostatic mechanisms, suggesting that use of oxytocin may interfere with appetite and weight (McCormack and others 2020). Although the extent of oxytocin’s effects in the brain and systemically are still poorly understood (Erdozain and Peñagarikano 2020), recent research suggests that it has promise as an effective therapeutic for many neurologic conditions (for review, see Cochran and others 2014). Although the patterns of oxytocin levels during pregnancy are still contentious, studies have demonstrated increases in oxytocin originating in the first trimester (Prevost and others 2014), within late pregnancy (Uvnäs-Moberg and others 2019), and during labor (Leake and others 1981). Moreover, levels within humans range quite significantly (Dawood and others 1979; Levine and others 2007), and there is currently no consensus on what a normal oxytocin level is. Evidence suggests that increases in oxytocin positively correlate to maternal-infant bonding quality (Kohlhoff and others 2017). A systematic review determined that mothers with more secure styles of parenting had higher levels of oxytocin when compared with mothers with a more insecure attachment style (Galbally and others 2011). The authors theorized that higher oxytocin levels provide increased interactions with the dopaminergic reward pathways, leading to a positive affective state when bonding with the infant. Rodent models, however, show that oxytocin levels and oxytocin receptor levels are linked to maternal care, as measured by observable licking and grooming behaviors (Francis and others 2000; Pedersen and Prange 1979). Oxytocin is highly conserved between rodents and humans, but the distribution of oxytocin receptors throughout the CNS may be species specific, which corresponds to differences in social and sexual behavior (Lim and Lajtha 2006).

Importantly for maternal trauma and ACEs, oxytocin is believed to regulate maternal-infant bonds (Galbally and others 2011) and is capable of modulating gene expression systemically and within the brain. See Figure 5 for overview of oxytocin generation and transmission. Although not examined in the context of early adversity, oxytocin treatment modified expression of the GR and mineralcorticoid (MR) genes in the hippocampus (Petersson and Uvnäs-Moberg 2003), as well as the epigenetic regulation of adipose- and angiogentic-related genes in adult rats (Eckertova and others 2011). Moreover, oxytocin levels in infancy are dynamic and can be epigenetically regulated by maternal care. High maternal engagement has been associated with increased expression of oxytocin in the offspring through changes in methylation of the OXTR gene (Krol, Moulder, and others 2019; Perkeybile and others 2019). Conversely, in adult clinical populations, acutely stressful events were capable of modifying methylation patterns of the OXTR gene (Unternaehrer and others 2012) with methylation status of the OXTR gene mediating the relationship between adversity (unmet material needs and neighborhood dysfunction) and depression (Simons and others 2017). The same is true for infants, where increased methylation of the OXTR gene was associated with enhanced activation of the inferior frontal cortex to fearful and angry stimuli but reduced activation of the same brain area in response to happy stimuli (Krol, Puglia, and others 2019). These results suggest that the oxytocin system is extremely plastic and susceptible to modification. Given that increases in methylation of the OXTR gene have been linked to a variety of neurologic conditions, such as autism spectrum disorder, anorexia nervosa, obsessive-compulsive disorder, depression, and anxiety (for review, see Kraaijenvanger and others 2019), it is plausible that early life manipulations, such as oxytocin administration, targeted toward decreased methylation of the OXTR gene could have beneficial effects, reducing an individual’s risk for the development of chronic pain. It is important to note, though, that oxytocin is believed to facilitate negative social emotions, including aggression, anger (Kemp and Guastella 2011), and withdrawal, and should therefore be explored in the context of perinatal trauma from a cautionary perspective.

Figure 5.

Oxytocin function and downstream effects. Oxytocin is synthesized within the hypothalamus and is projected to other regions of the brain or travels to the posterior pituitary gland where it is secreted to the periphery via the circulatory system. It exerts effects on mammary glands, uterine contractions, gut motility, and renal inflammation. In the case of uterine contractions and breast milk production, these functions can induce a positive feedback loop resulting in increased oxytocin production. Pregnancy induces an increase in oxytocin production, as do environmental factors such as physical touch, pets, or pharmacologic intervention.

Another potential therapeutic to improve the deficits associated with early adversity may be probiotics. Given that many “brain-centric” therapeutics have failed to adequately improve chronic pain outcomes, there is a need to expand on traditional strategies. Similar to oxytocin, probiotics target systemic processes and may therefore provide greater benefit for chronic pain symptomology associated with perinatal trauma. Probiotics are consumable forms of live bacteria that are hypothesized to be beneficial for human health. They can occur naturally in foods or be taken as supplements, and they are consumed to benefit gastrointestinal health. However, research conducted within the last decade has demonstrated that bacteria can exercise significant influence on other regions within the body and, in particular, play an important role in regulation of CNS functions (Cryan and others 2019). The gut microbiota and the brain have bidirectional communication, known as the gut-brain axis, which has been shown to affect white matter architecture (Ong and others 2018), microglial phenotypes (Wang and others 2018), and neurotransmitter activity (González-Arancibia and others 2019; Reigstad and others 2015; Strandwitz 2018). Rodent models have revealed that probiotic administration induces improved maternal behaviors (O’Leary 2019). Yet, these results have yet to be replicated in human populations (Rutten and others 2016). Probiotics have had a beneficial impact on offspring, alleviating anxiety- and depression-related symptoms (Liu and others 2019), which are common long-term consequences associated with ACEs (Lee and others 2020). Administration of Bifidobacterium infantis in rodents exposed to maternal separation increased pain thresholds (McKernan and others 2010) and stabilized noradrenaline levels within the brain (Desbonnet and others 2010). Although this study did not investigate any outcomes related to chronic pain development, it did confirm alleviation of depressive-like behavior induced by ACEs, which is a common comorbidity associated with chronic pain.

There have been multiple studies investigating pain and nociceptive behaviors in rodents exposed to gut microbiome manipulations (Amaral and others 2008; Verdú and others 2006). For example, inflammatory-induced nociception was reduced in mice lacking a gut microbiome, suggesting that the microbiota are important in the development of the nociceptive response (Amaral and others 2008). Similarly altered gut microbiome profiles resulted in decreases to neuropeptides such as substance P (Verdú and others 2006), which are known to modify nociceptive perception within the CNS. Administration of Lactobacillus acidophilus increased expression of multiple receptor types within the gut, including μ-opioid and cannabinoid receptors, and regulated analgesic responses in a rodent model (Rousseaux and others 2007). Although the neurobiological mechanisms are not fully elucidated, epigenetic factors are potentially involved. Microbiota have been demonstrated to modulate epigenetic mechanisms in models of depression (Zalar and others 2018). Few studies have focused on these factors in pain pathology, but it has been established that they influence neurologic processes. Within chronic pain models, there is existing research on probiotic therapies in irritable bowel syndrome or similar conditions and their associated pain (Roman and others 2018). More widespread chronic pain profiles are yet to be investigated. However, the current evidence does suggest that bacteria are able to influence CNS outcomes (Ghaisas and others 2016). As such, probiotics represent a potential and relatively safe therapeutic that may alleviate symptoms associated with ACEs, as well as CNS changes associated with chronic pain.

Conclusion

Chronic pain is a highly burdensome disease that significantly reduces quality of life. It is becomingly increasingly evident that early life trauma, pre- and postnatal, influences molecular mechanisms, namely epigenetic regulation, which may lead to large-scale cortical reorganization that underlies the chronification of pain. These epigenetic mechanisms may provide an effective mechanism to improve chronic pain management while targeting the comorbid symptoms. Understanding how these factors combine and interact is vital to providing individualized care and ultimately reducing the detrimental role that chronic pain plays in the lives of millions of people. Personalized medicine, tailored to not only the epigenome but also the environmental conditions of an individual, would be a substantial advancement in clinical care. Moreover, given the significant evidence demonstrating sex differences within epigenetic processes, neurodevelopment, and chronic pain prevalence, this remains an important area of research worthy of future consideration. Most important, well-designed and robust animal models can be used to better address chronic pain in the clinic, if we can improve our understanding of how genes and the perinatal environmental combine to influence neural architecture and connectivity.

Footnotes

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: RM received funding from NHMRC (#1173565) for the authorship, and/or publication of this article.

ORCID iDs

Sandy R. Shultz

Richelle Mychasiuk

References

Aisa

Tordera

Lasheras

Del Río

Ramírez

. 2007. Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats. Psychoneuroendocrinology 32(3):256–66.

Amaral

Sachs

Costa

Fagundes

Cisalpino

Cunha

, and others. 2008. Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A 105(6):2193–7.

Apkarian

Sosa

Sonty

Levy

Harden

Parrish

, and others. 2004. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 24(46):10410–5.

Arain

Haque

Johal

Mathur

Nel

Rais

, and others. 2013. Maturation of the adolescent brain. Neuropsychiatr Dis Treat 9:449–61.

Aroke

Overstreet

Penn

Crossman

Jackson

Tollefsbol

, and others. 2020. Identification of DNA methylation associated enrichment pathways in adults with non-specific chronic low back pain. Mol Pain 16:1744806920972889.

Bâ

Seri

. 1993. Functional development of central nervous system in the rat: ontogeny of nociceptive thresholds. Physiol Behav 54(2):403–5.

Bale

. 2011. Sex differences in prenatal epigenetic programming of stress pathways. Stress 14(4):348–56.

Baliki

Petre

Torbey

Herrmann

Huang

Schnitzer

, and others. 2012. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat Neurosci 15(8):1117–9.

Baliki

Schnitzer

Bauer

Apkarian

. 2011. Brain morphological signatures for chronic pain. PLoS One 6:e26010.

10.

Ballantyne

Shin

. 2008. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain 24(6):469–78.

11.

Bannister

Kouzarides

2011. Regulation of chromatin by histone modifications. Cell Res 21(3):381–95.

12.

Basil

Dempster

Mill

Sham

Wong

CCY

, and others. 2014. Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain. Transl Psychiatry 4(9):e434.

13.

Bathina

Das

. 2015. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sol 11:1164–78.

14.

Berger

Barros

Sarchi

Tarazi

Antonelli

. 2002. Long-term effects of prenatal stress on dopamine and glutamate receptors in adult rat brain. Neurochem Res 27(11):1525–33.

15.

Beveridge

Yeates

Madigan

Stone

Wilson

, and others. 2022. Examining parent adverse childhood experiences as a distal risk factor in pediatric chronic pain. Clin J Pain 38(2):95–107.

16.

Bhandari

Dosanjh

Tornetta

Matthews

2006. Musculoskeletal manifestations of physical abuse after intimate partner violence. J Trauma Inj Infect Crit Care 61(6):1473–9.

17.

Biswas

Voltz

Smith

Langowski

2011. Role of histone tails in structural stability of the nucleosome. PLOS Comput Biol 7(12):e1002279.

18.

Bjersing

Lundborg

Bokarewa

Mannerkorpi

2013. Profile of cerebrospinal microRNAs in fibromyalgia. PLoS One 8(10):e78762.

19.

Blanks

Thornton

2003. The role of oxytocin in parturition. BJOG Int J Obstet Gynaecol 110 Suppl 20:46–51.

20.

Blyth

March

Brnabic

AJM

Jorm

Williamson

Cousins

. 2001. Chronic pain in Australia: a prevalence study. Pain 89(2):127–34.

21.

Boullier

Blair

2018. Adverse childhood experiences. Paediatr Child Health 28(3):132–7.

22.

Brown

Diaz

Robson

Kotelevtsev

Mullins

Kaufman

, and others. 1996. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 137(2):794–7.

23.

Buchheit

Van de Ven

Shaw

2012. Epigenetics and the transition from acute to chronic pain. Pain Med 13(11):1474–90.

24.

Bücker

Fries

Kapczinski

Post

Yatham

Vianna

, and others. 2015. Brain-derived neurotrophic factor and inflammatory markers in school-aged children with early trauma. Acta Psychiatr Scand 131(5):360–8.

25.

Bugg

Siddiqui

Thornton

. 2013. Oxytocin versus no treatment or delayed treatment for slow progress in the first stage of spontaneous labour. Cochrane Database of Systematic Reviews 6:CD007123.

26.

Buss

Davis

Hobel

Sandman

. 2011. Maternal pregnancy-specific anxiety is associated with child executive function at 6–9 years age. Stress 14(6):665–76.

27.

Buss

Davis

Shahbaba

Pruessner

Head

Sandman

. 2012. Maternal cortisol over the course of pregnancy and subsequent child amygdala and hippocampus volumes and affective problems. Proc Natl Acad Sci U S A 109(20):E1312–9.

28.

Campbell

Anderson

McFadgion

Gill

Zink

Patch

, and others. 2018. The effects of intimate partner violence and probable traumatic brain injury on central nervous system symptoms. J Womens Health 27(6):761–7.

29.

Campo

. 2015. Domestic and family violence in pregnancy and early parenthood: Overview and emerging interventions [accessed 5 Aug 2022]. https://aifs.gov.au/resources/policy-and-practice-papers/domestic-and-family-violence-pregnancy-and-early-parenthood.

30.

Capron

Ramchandani

Glover

2018. Maternal prenatal stress and placental gene expression of NR3C1 and HSD11B2: the effects of maternal ethnicity. Psychoneuroendocrinology 87:166–72.

31.

Chang

Yeo

Joshi

2022. Resilience as a protective factor in face of pain symptomology, disability, and psychological outcomes in adult chronic pain populations: a scoping review. Scand J Pain 23(2):228–50.

32.

Chibber

Krishnan

2011. Confronting intimate partner violence: a global health care priority. Mt Sinai J Med 78(3):449–57.

33.

Cochran

Fallon

Hill

Frazier

2014. The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harv Rev Psychiatry 21(5):219–47.

34.

Cryan

O’Riordan

Cowan

CSM

Sandhu

Bastiaanssen

TFS

Boehme

, and others. 2019. The microbiota-gut-brain axis. Physiol Rev 99:1877–2013.

35.

Davis

Luecken

Zautra

. 2005. Are reports of childhood abuse related to the experience of chronic pain in adulthood? A meta-analytic review of the literature. Clin J Pain 21(5):398–405.

36.

Dawood

Ylikorkala

Trivedi

1979. Oxytocin in maternal circulation and amniotic fluid during pregnancy. J Clin Endocrinol Metab 49(3):429–34.

37.

Denk

McMahon

. 2012. Chronic pain: emerging evidence for the involvement of epigenetics. Neuron 73(3):435–44.

38.

Desbonnet

Garrett

Clarke

Kiely

Cryan

Dinan

. 2010. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170(4):1179–88.

39.

Donovan

Spracklen

Schweizer

Ryckman

Saftlas

2016. Intimate partner violence during pregnancy and the risk for adverse infant outcomes: a systematic review and meta-analysis. BJOG Int J Obstet Gynaecol 123(8):1289–99.

40.

Dumas

Pollack

. 2008. Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. AAPS J 10(4):537.

41.

Eckertova

Ondrejcakova

Krskova

Zorad

Jezova

2011. Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesis. Br J Pharmacol 162(2):452.

42.

Eller

Glidden

Knight

McKearney

Perry

Bernier Carney

, and others. 2021. A role for global DNA methylation level and IL2 expression in the transition from acute to chronic low back pain. Front Pain Res 2:744148.

43.

Elwenspoek

MMC

Kuehn

Muller

Turner

. 2017. The effects of early life adversity on the immune system. Psychoneuroendocrinology 82:140–54.

44.

Erdozain

Peñagarikano

2020. Oxytocin as treatment for social cognition, not there yet. Frontiers in Psychiatry 10:930.

45.

Fan

Martinowich

Chin

Fouse

Hutnick

, and others. 2005. DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling. Development 132(15):3345–56.

46.

Felitti

Anda

Nordenberg

Williamson

Spitz

Edwards

, and others. 1998. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) Study. Am J Prev Med 14(4):245–58.

47.

Fine

Zhang

Stevens

. 2014. Prenatal stress and inhibitory neuron systems: implications for neuropsychiatric disorders. Mol Psychiatry 19(6):641–51.

48.

Finkelhor

Shattuck

Turner

Hamby

2015. A revised inventory of adverse childhood experiences. Child Abuse Negl 48:13–21.

49.

Francis

Champagne

Meaney

. 2000. Variations in maternal behaviour are associated with differences in oxytocin receptor levels in the rat. J Neuroendocrinol 12(12):1145–8.

50.

Galbally

Lewis

Ijzendoorn

M van

Permezel

2011. The role of oxytocin in mother-infant relations: a systematic review of human studies. Harv Rev Psychiatry 19(1):1–14.

51.

Gantz

Ford

Neve

Williams

. 2011. Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway. J Neurosci 31(35):12629–37.

52.

Garcia-Moreno

Jansen

HAFM

Ellsberg

, and others. 2005. WHO multi-country study on women’s health and domestic violence against women: initial results on prevalence, health outcomes and women’s responses [accessed 5 Aug 2022]. https://apps.who.int/iris/handle/10665/43309.

53.

Garriga

Laumet

Chen

Zhang

Madzo

Issa

, and others. 2018. Nerve injury-induced chronic pain is associated with persistent DNA methylation reprogramming in dorsal root ganglion. J Neurosci 38(27):6090–101.

54.

Geha

Baliki

Harden

Bauer

Parrish

Apkarian

. 2008. The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 60(4):570–81.

55.

Ghaisas

Maher

Kanthasamy

2016. Gut microbiome in health and disease: linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol Ther 158:52–62.

56.

Gicquel

El-Osta

Le Bouc

2008. Epigenetic regulation and fetal programming. Best Pract Res Clin Endocrinol Metab 22(1):1–16.

57.

Gilmore

Knickmeyer

Gao

2018. Imaging structural and functional brain development in early childhood. Nat Rev Neurosci 19(3):123–37.

58.

Godfrey

Barker

. 2001. Fetal programming and adult health. Public Health Nutr 4(2B):611–24.

59.

Gölzenleuchter

Kanwar

Zaibak

Al Saiegh

Hartung

Klukas

, and others. 2015. Plasticity of DNA methylation in a nerve injury model of pain. Epigenetics 10(3):200–12.

60.

González-Arancibia

Urrutia-Piñones

Illanes-González

Martinez-Pinto

Sotomayor-Zárate

Julio-Pieper

, and others. 2019. Do your gut microbes affect your brain dopamine? Psychopharmacology 236(5):1611–22.

61.

Gracely

Geisser

Giesecke

Grant

MAB

Petzke

Williams

, and others. 2004. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 127(4):835–43.

62.

Gracia

. 2004. Unreported cases of domestic violence against women: towards an epidemiology of social silence, tolerance, and inhibition. J Epidemiol Community Health 58(7):536–7.

63.

Groenewald

Murray

Palermo

. 2020. Adverse childhood experiences and chronic pain among children and adolescents in the United States. Pain Rep 5(5):e839.

64.

Guan

Haggarty

Giacometti

Dannenberg

Joseph

Gao

, and others. 2009. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459(7243):55–60.

65.

Guan

Giustetto

Lomvardas

Kim

Miniaci

Schwartz

, and others. 2002. Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 111(4):483–93.

66.

Haahr-Pedersen

Perera

Hyland

Vallières

Murphy

Hansen

, and others. 2020. Females have more complex patterns of childhood adversity: implications for mental, social, and emotional outcomes in adulthood. Eur J Psychotraumatology 11(1):1708618.

67.

Hadi

McHugh

Closs

. 2019. Impact of chronic pain on patients’ quality of life: a comparative mixed-methods study. J Patient Exp 6(2):133–41.

68.

Hähle

Merz

Meyners

Hausch

2019. The many faces of FKBP51. Biomolecules 9(1):35.

69.

Han

Patel

Jones

Dale

. 2021. Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat Rev Neurol 17(9):564–79.

70.

Hattori

Nishino

Hattori

Ohgane

Tanaka

, and others. 2004. Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J Biol Chem 279(17):17063–9.

71.

Hehar

Mychasiuk

2015. Do fathers matter: influencing neural phenotypes through non-genetic transmission of paternal experiences? Non-genetic Inheritance 2:23–31.

72.

Hellmuth

Leonard

. 2013. Methods for assessing and addressing participant protection concerns in intimate partner violence research. Partn Abuse 4(4):482–93.

73.

Hobo

Eisenach

Hayashida

2011. Up-regulation of spinal glutamate transporters contributes to anti-hypersensitive effects of valproate in rats after peripheral nerve injury. Neurosci Lett 502(1):52–5.

74.

Hocher

. 2014. More than genes: the advanced fetal programming hypothesis. J Reprod Immunol 104–5:8–11.

75.

Hong

Zheng

Wiley

. 2015. Epigenetic regulation of genes that modulate chronic stress-induced visceral pain in the peripheral nervous system. Gastroenterology 148(1):148–57.e7.

76.

Howlett

Reik

1991. Methylation levels of maternal and paternal genomes during preimplantation development. Development 113(1):119–27.

77.

Ignatowski

Covey

Knight

Severin

Nickola

Spengler

. 1999. Brain-derived TNFα mediates neuropathic pain. Brain Res, 841(1–2):70–7.

78.

Irwin

Meyering

Peterson

Glynn

Sandman

Hicks

, and others. 2021. Maternal prenatal cortisol programs the infant hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 125:105106.

79.

Ito

Barnes

Adcock

. 2000. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20(18):6891–903.

80.

Jensen

Finnerup

. 2014. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol 13(9):924–35.

81.

Kohno

Moore

Woolf

. 2003. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26(12):696–705.

82.

Kalmakis

Chandler

. 2015. Health consequences of adverse childhood experiences: a systematic review. J Am Assoc Nurse Pract 27(8):457–65.

83.

Kang

McAuley

Kassem

Gatt

Gustin

. 2019. What does the grey matter decrease in the medial prefrontal cortex reflect in people with chronic pain? Eur J Pain 23(2):203–19.

84.

Kelly

Huang

Meltzer

Martina

2016. Reduced glutamatergic currents and dendritic branching of layer 5 pyramidal cells contribute to medial prefrontal cortex deactivation in a rat model of neuropathic pain. Front Cell Neurosci 10:133.

85.

Kemp

Guastella

. 2011. The role of oxytocin in human affect: a novel hypothesis. Curr Dir Psychol Sci 20(4):222–31.

86.

Kessler

Amminger

Aguilar-Gaxiola

Alonso

Lee

Ustun

. 2007. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry 20(4):359–64.

87.

King

Chambers

Huguet

MacNevin

McGrath

Parker

, and others. 2011. The epidemiology of chronic pain in children and adolescents revisited: a systematic review. Pain 152(12):2729–38.

88.

Klengel

Mehta

Anacker

Rex-Haffner

Pruessner

Pariante

, and others. 2013. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 16(1):33–41.

89.

Knickmeyer

Gouttard

Kang

Evans

Wilber

Smith

, and others. 2008. A structural MRI study of human brain development from birth to 2 years. J Neurosci 28(47):12176–82.

90.

Knickmeyer

Wang

Zhu

Geng

Woolson

Hamer

, and others. 2014. Impact of sex and gonadal steroids on neonatal brain structure. Cereb Cortex 24(10):2721–31.

91.

Kohlhoff

Eapen

Dadds

Khan

Silove

Barnett

2017. Oxytocin in the postnatal period: associations with attachment and maternal caregiving. Compr Psychiatry 76:56–68.

92.

Kossintseva

Wong

Johnstone

Guilbert

Olson

Mitchell

. 2006. Proinflammatory cytokines inhibit human placental 11beta-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP pathways. Am J Physiol Endocrinol Metab 290(2):E282–8.

93.

Kraaijenvanger

Spender

Smith

Bos

Boks

MPM

. 2019. Epigenetic variability in the human oxytocin receptor (OXTR) gene: a possible pathway from early life experiences to psychopathologies. Neurosci Biobehav Rev 96:127–42.

94.

Krol

Moulder

Lillard

Grossmann

Connelly

. 2019. Epigenetic dynamics in infancy and the impact of maternal engagement. Sci Adv 5(10):eaay0680.

95.

Krol

Puglia

Morris

Conelly

Grossman

2019. Epigenetic modification of the oxytocin receptor gene is associated with emotion processing in the infant brain. Dev Cogn Neurosci 37:100648.

96.

Kuchinad

Schweinhardt

Seminowicz

Wood

Chizh

Bushnell

. 2007. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci 27(15):4004–7.

97.

Kuhlman

Horn

Chiang

Bower

. 2020. Early life adversity exposure and circulating markers of inflammation in children and adolescents: a systematic review and meta-analysis. Brain, Behavior and Imm 86:30–42.

98.

Kynast

Russe

Möser

Geisslinger

Niederberger

2013. Modulation of central nervous system-specific microRNA-124a alters the inflammatory response in the formalin test in mice. Pain 154(3):368–76.

99.

Labouesse

Dong

Grayson

Guidotti

Meyer

2015. Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex. Epigenetics 10(12):1143–55.

100.

Lagger

O’Carroll

Rembold

Khier

Tischler

Weitzer

, and others. 2002. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 21(11):2672–81.

101.

Leake

Weitzman

Glatz

Fisher

. 1981. Plasma oxytocin concentrations in men, nonpregnant women, and pregnant women before and during spontaneous labor. J Clin Endocrinol Metab 53(4):730–33.

102.

Lee

Kim

Nam

Jeong

2020. Adverse childhood experiences and the associations with depression and anxiety in adolescents. Child Youth Serv Rev 111:104850.

103.

Levenson

O’Riordan

Brown

Trinh

Molfese

Sweatt

. 2004. Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 279(39):40545–59.

104.

Levine

Zagoory-Sharon

Feldman

Weller

2007. Oxytocin during pregnancy and early postpartum: individual patterns and maternal-fetal attachment. Peptides 28(6):1162–9.

105.

Wang

Chen

Dong

Shuai

Xiao

, and others. 2012. Late gestational maternal serum cortisol is inversely associated with fetal brain growth. Neurosci Biobehav Rev 36:1085–92.

106.

Zhang

Liu

Chu

Jiang

, and others. 2015. Small non-coding RNAs transfer through mammalian placenta and directly regulate fetal gene expression. Protein Cell 6(6):391–6.

107.

Lim

Lajtha

2006. Handbook of neurochemistry and molecular neurobiology. Berlin (Germany): Springer Science & Business Media.

108.

Lind

Spagopoulou

2018. Evolutionary consequences of epigenetic inheritance. Heredity (Edinb) 121(3):205–9.

109.

Liu

Walsh

RFL

Sheehan

. 2019. Prebiotics and probiotics for depression and anxiety: a systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev 102:13–23.

110.

López-González

Landry

Favereaux

2017. MicroRNA and chronic pain: from mechanisms to therapeutic potential. Pharmacol Ther 180:1–15.

111.

Madison

Malenka

Nicoll

. 1991. Mechanisms underlying long-term potentiation of synaptic transmission. Ann Rev Neurosci 14:379–97.

112.

Maiarù

Tochiki

Cox

Annan

Bell

Feng

, and others. 2016. The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling. Sci Transl Med 8(325):325ra19.

113.

Marchand

Perretti

McMahon

. 2005. Role of the immune system in chronic pain. Nat Rev Neurosci 6(7):521–32.

114.

Mariño-Ramírez

Kann

Shoemaker

Landsman

2005. Histone structure and nucleosome stability. Expert Rev Proteomics 2(5):719–29.

115.

Marsh

Lee

Hurlemann

2021. Oxytocin and the neurobiology of prosocial behavior. Neuroscientist 27(6):604–19.

116.

Martin

Mackie

Kupper

Buescher

Moracco

. 2001. Physical abuse of women before, during, and after pregnancy. JAMA 285(12):1581–4.

117.

Massart

Dymov

Millecamps

Suderman

Gregoire

Koenigs

, and others. 2016. Overlapping signatures of chronic pain in the DNA methylation landscape of prefrontal cortex and peripheral T cells. Sci Rep 6(1):19615.

118.

Mattern

Post

Solger

O’Leary

Slattery

Reif

, and others. 2019. Prenatal and postnatal experiences associated with epigenetic changes in the adult mouse brain. Behav Brain Res 359:143–8.

119.

Matz

Vogel

Mattar

Montenegro

2015. Interrupting intergenerational trauma: children of Holocaust survivors and the Third Reich. J Phenomenol Psychol 46(2):185–205.

120.

McCormack

Blevins

Lawson

. 2020. Metabolic Effects of Oxytocin. Endocr Rev 41(2):121–45.

121.

McGowan

Sasaki

D’Alessio

Dymov

Labonté

Szyf

, and others. 2009. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12(3):article 3.

122.

McKernan

Fitzgerald

Dinan

Cryan

. 2010. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil 22(9):1029-e268.

123.

Meany

Szyf

Seckl

JR.

2007. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends Mol Med 13:269–77.

124.

MedlinePlus Genetics. 2022. MECP2 gene [accessed 14 Nov 2022]. https://medlineplus.gov/genetics/gene/mecp2/.

125.

Miranda

Morici

Zanoni

Bekinschtein

2019. Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci 13:363.

126.

Mohn

Schübeler

2009. Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet 25(3):129–36.

127.

Mojahed

Alaidarous

Kopp

Pogarell

Thiel

Garthus-Niegel

2021. Prevalence of intimate partner violence among intimate partners during the perinatal period: a narrative literature review. Front Psychiatry 12:601236.

128.

Monahan

Bannon

Dams-O’Connor

2022. Nonfatal strangulation (NFS) and intimate partner violence: a brief overview. J Fam Violence 37(1):75–86.

129.

Moore

Fan

2013. DNA methylation and its basic function. Neuropsychopharmacology 38(1).

130.

Mychasiuk

. 2015. Epigenetics of brain plasticity and behavior. In: Wright

, editor. International encyclopedia of the social and behavioral sciences. 2nd ed. Amsterdam (Netherlands): Elsevier. p. 848–51.

131.

Mychasiuk

Gibb

Kolb

2011. Prenatal stress produces sexually dimorphic and regionally specific changes in gene expression in hippocampus and frontal cortex of developing rat offspring. Dev Neurosci 33(6):531–8.

132.

Nakagawa

Wada

Katada

Kishi

2020. Epigenetic regulation for acquiring glial identity by neural stem cells during cortical development. Glia 68(8):1554–67.

133.

Nan

Campoy

Bird

1997. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88(4):471–81.

134.

Naylor

Hesam-Shariati

McAuley

Boag

Newton-John

Rae

, and others. 2019. Reduced glutamate in the medial prefrontal cortex is associated with emotional and cognitive dysregulation in people with chronic pain. Front Neurol 10:1110.

135.

NCBI. 2022. NR3C1 nuclear receptor subfamily 3 group C member 1 [Homo sapiens (human)]—gene [accessed 4 Nov 2022]. https://www.ncbi.nlm.nih.gov/gene/2908.

136.

Neugebauer

Bird

Han

. 2004. The amygdala and persistent pain. Neuroscientist 10(3):221–34.

137.

Nimbley

Caes

Noel

Jordan

2023. Distress and resilience narratives within pain memories of adolescents and young adults with complex regional pain syndrome: a multi-method study. J Pain. doi:10.1016/j.jpain.2023.02.025.

138.

O’Donnell

Bugge Jensen

Freeman

Khalife

O’Connor

Glover

2012. Maternal prenatal anxiety and downregulation of placental 11β-HSD2. Psychoneuroendocrinology 37(6):818–26.

139.

Okano

Bell

Haber

1999. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3):247–57.

140.

O’Leary

. 2019. Maternal microbes: the effects of probiotic treatment on maternal care behaviour, inflammation and offspring stress outcomes. Masters of science thesis. Halifax (Nova Scotia): Dalhousie University.

141.

Ong

Gonzalez

McIlwain

Sawin

Schoen

Adluru

, and others. 2018. Gut microbiome populations are associated with structure-specific changes in white matter architecture. Transl Psychiatry 8(1):6.

142.

Ong

Stohler

Herr

. 2019. Role of the prefrontal cortex in pain processing. Mol Neurobiol 56(2):1137–66.

143.

Palma-Gudiel

Córdova-Palomera

Eixarch

Deuschle

Fañanás

2015. Maternal psychosocial stress during pregnancy alters the epigenetic signature of the glucocorticoid receptor gene promoter in their offspring: a meta-analysis. Epigenetics 10(10):893–902.

144.

Pastor-Moreno

Ruiz-Pérez

Henares-Montiel

Petrova

2020. Intimate partner violence during pregnancy and risk of fetal and neonatal death: a meta-analysis with socioeconomic context indicators. Am J Obstet Gynecol 222(2):123–33.e5.

145.

Paus

Keshavan

Giedd

. 2008. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 9(12):947–57.

146.

Payne

. 2000. Limitations of NSAIDs for pain management: toxicity or lack of efficacy? J Pain 1(3, Suppl):14–8.

147.

Pedersen

Prange

Jr.

1979. Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. Proc Natl Acad Sci U S A 76(12):6661–5.

148.

Perkeybile

Carter

Wroblewski

Puglia

Kenkel

Lillard

, and others. 2019. Early nurture epigenetically tunes the oxytocin receptor. Psychoneuroendocrinology 99:128–36.

149.

Perroud

Paoloni-Giacobino

Prada

Olié

Salzmann

Nicastro

, and others. 2011. Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Transl Psychiatry 1(12):e59.

150.

Petersson

Uvnäs-Moberg

2013. Systemic oxytocin treatment modulates glucocorticoid and mineralocorticoid receptor mRNA in the rat hippocampus. Neurosci Lett 343:97–100.

151.

Plank

Frey

Basedow

Solati

Canneva

von Hörsten

, and others. 2021. Prenatally traumatized mice reveal hippocampal methylation and expression changes of the stress-related genes Crhr1 and Fkbp5. Transl Psychiatry 11(1):183.

152.

Polli

Hendrix

Ickmans

Bakusic

Ghosh

Monteyne

, and others. 2022. Genetic and epigenetic regulation of catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and fibromyalgia. J Transl Med 20(1):487.

153.

Pollema-Mays

Centeno

Apkarian

Martina

2014. Expression of DNA methyltransferases in adult dorsal root ganglia is cell-type specific and up regulated in a rodent model of neuropathic pain. Front Cell Neurosci 8:217.

154.

Prevost

Zelkowitz

Tulandi

Hayton

Feeley

Carter

, and others. 2014. Oxytocin in pregnancy and the postpartum: relations to labor and its management. Front Public Health 2:1.

155.

PubChem. 2022a. FKBP5—FKBP prolyl isomerase 5 (human) [accessed 28 Nov 2022]. https://pubchem.ncbi.nlm.nih.gov/gene/FKBP5/human.

156.

PubChem. 2022b. TNF—tumor necrosis factor (human) [accessed 29 Oct 2022]. https://pubchem.ncbi.nlm.nih.gov/gene/TNF/human.

157.

Radtke

Ruf

Gunter

Dohrmann

Schauer

Meyer

, and others. 2011. Transgenerational impact of intimate partner violence on methylation in the promoter of the glucocorticoid receptor. Transl Psychiatry 1(7):e21.

158.

Rahman

Gilmour

Jimenez

MacNee

2002. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 234–35(1–2):239–48.

159.

Reigstad

Salmonson

Lii

JFR

Szurszewski

Linden

Sonnenburg

, and others. 2015. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 29(4):1395–403.

160.

Rentesi

Antoniou

Marselos

Syrrou

Papadopoulou-Daifoti

Konstandi

2013. Early maternal deprivation-induced modifications in the neurobiological, neurochemical and behavioral profile of adult rats. Behav Brain Res 244:29–37.

161.

Roman

Abalo

Marco

Cardona

2018. Probiotics in digestive, emotional, and pain-related disorders. Behav Pharmacol 29:103–19.

162.

Roth

Lubin

Funk

Sweatt

. 2009. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 65(9):760–9.

163.

Rousseaux

Thuru

Gelot

Barnich

Neut

Dubuquoy

, and others. 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 13(1):35–7.

164.

Ruiz-Pérez

Plazaola-Castaño

Vives-Cases

2007. Methodological issues in the study of violence against women. J Epidemiol Community Health 61 Suppl 2:ii26–ii31.

165.

Rutten

Van der Gugten

Uiterwaal

Vlieger

Rijkers

Van der Ent

2016. Maternal use of probiotics during pregnancy and effects on their offspring’s health in an unselected population. Eur J Pediatr 175(2):229–35.

166.

Saber

Ortiz

Rojas Valencia

Tallent

Adelson

, and others. 2021. Mice born to mothers with gravida traumatic brain injury have distorted brain circuitry and altered immune responses. J Neurotrauma 38(20):2862–80.

167.

Salinas

Connolly

Song

2020. Epigenetics in Neurodevelopment. Neuropathol Appl Neurobiol 46(1):6–27.

168.

Sandman

Glynn

Davis

. 2013. Is there a viability-vulnerability tradeoff? Sex differences in fetal programming. J Psychosom Res 75(4):327–35.

169.

Sardinha

Maheu-Giroux

Stöckl

Meyer

García-Moreno

2022. Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018. Lancet 399(10327):803–13.

170.

Schäfers

Geis

Svensson

Luo

Sommer

2003. Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci 17(4):791–804.

171.

Schmidt-Wilcke

Leinisch

Straube

Kämpfe

Draganski

Diener

, and others. 2005. Gray matter decrease in patients with chronic tension type headache. Neurology 65(9):1483–6.

172.

Schratt

Tuebing

Nigh

Kane

Sabatini

Kiebler

, and others. 2006. A brain-specific microRNA regulates dendritic spine development. Nature 439(7074):283–9.

173.

Scott

Habas

Kim

Rajagopalan

Hamzelou

Corbett-Detig , and others. 2011. Growth trajectories of the human fetal brain tissues estimated from 3D reconstructed in utero MRI. Int J Dev Neurosci 29(5):529–36.

174.

Seto

Yoshida

2014. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect in Biol 6(4):a018713.

175.

Sevel

Letzen

Staud

Robinson

. 2016. Interhemispheric dorsolateral prefrontal cortex connectivity is associated with individual differences in pain sensitivity in healthy controls. Brain Connect 6(5):357–64.

176.

Shields

LBE

Corey

Weakley-Jones

Stewart

. 2010. Living victims of strangulation: a 10-year review of cases in a metropolitan community. Am J Forensic Med Pathol 31(4):320–5.

177.

Sikandar

Minett

Millet

Santana-Varela

Lau

Wood

, and others. 2018. Brain-derived neurotrophic factor derived from sensory neurons plays a critical role in chronic pain. Brain 141(4):1028–39.

178.

Simons

Lei

Beach

SRH

Cutrona

Philibert

. 2017. Methylation of the oxytocin receptor gene mediates the effect of adversity on negative schemas and depression. Dev Psychopathol 29(3):725.

179.

Strandwitz

. 2018. Neurotransmitter modulation by the gut microbiota. Brain Res, 1693:128–33.

180.

Szczesny

Basta-Kaim

Slusarczyk

Trojan

Glombik

Regulska

, and others. 2014. The impact of prenatal stress on insulin-like growth factor-1 and pro-inflammatory cytokine expression in the brains of adult male rats: the possible role of suppressors of cytokine signaling proteins. J Neuroimmunol 276(1):37–46.

181.

Tachibana

Sugimoto

Nozaki

Ueda

Ohta

Ohki

, and others. 2002. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16(14):1779–91.

182.

Tafuri

Santovito

de Nardis

Marcantonio

Paganelli

Affaitati

, and others. 2015. MicroRNA profiling in migraine without aura: pilot study. Ann Med 47(6):468–73.

183.

Tajerian

Alvarado

Millecamps

Vachon

Crosby

Bushnell

, and others. 2013. Peripheral nerve injury is associated with chronic, reversible changes in global DNA methylation in the mouse prefrontal cortex. PloS One 8(1):e55259.

184.

Takizawa

Nakashima

Namihira

Ochiai

Uemura

Yanagisawa

, and others. 2001. DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain. Dev Cell 1(6):749–58.

185.

Tan

. 2013. Alterations in physiology and anatomy during pregnancy. Best Pract Res Clin Obstet Gynaecol 27:791–802.

186.

Tao

Chen

Wang

Zhou

Jin

Mao

, and others. 2020. MeCP2 mediates transgenerational transmission of chronic pain. Prog Neurobiol 189:101790.

187.

Tierney

Nelson

. 2009. Brain development and the role of experience in the early years. Zero Three 30(2):9–13.

188.

Tottenham

Hare

Millner

Gilhooly

Zevin

Casey

. 2011. Elevated amygdala response to faces following early deprivation. Dev Sci 14(2):190–204.

189.

Treede

Rief

Barke

Aziz

Bennett

Benoliel

, and others. 2015. A classification of chronic pain for ICD-11. Pain 156(6):1003–7.

190.

Trollope

Gutièrrez-Mecinas

Mifsud

Collins

Saunderson

Reul

JMHM

. 2012. Stress, epigenetic control of gene expression and memory formation. Exp Neurol 233(1):3–11.

191.

Turner

. 2000. Histone acetylation and an epigenetic code. BioEssays 22(9):836–45.

192.

Tunks

Crook

Weir

2008. Epidemiology of chronic pain with psychological comorbidity: prevalance, risk, course, and prognosis. Pain 53(4):224–34.

193.

Udo

Sharps

Bronner

Hossain

. 2016. Maternal intimate partner violence: relationships with language and neurological development of infant and toddlers. Matern Child Health J 20(7):1424–31.

194.

United Nations Human Rights Office of the High Commisioner. 1993. Declaration on the elimination of violence against women [accessed 5 Aug 2022]. https://digitallibrary.un.org/record/179739?ln=en.

195.

Unternaehrer

Luers

Mill

Dempster

Meyer

Staehli

, and others. 2012. Dynamic changes in DNA methylation of stress-associated genes (OXTR, BDNF) after acute psychosocial stress. Transl Psychiatry 2(8):e150.

196.

Uvnäs-Moberg

Ekström-Bergström

Berg

Buckley

Pajalic

Hadjigeorgiou

, and others. 2019. Maternal plasma levels of oxytocin during physiological childbirth—a systematic review with implications for uterine contractions and central actions of oxytocin. BMC Pregnancy Childbirth 19(1):285.

197.

Uysal

Akkoyunlu

Ozturk

2015. Dynamic expression of DNA methyltransferases (DNMTs) in oocytes and early embryos. Biochim Open 116:103–13.

198.

Vachon-Presseau

Centeno

Ren

Berger

Tétreault

Ghantous

, and others. 2016. The emotional brain as a predictor and amplifier of chronic pain. J Dent Res 95(6):605–12.

199.

Van der Auwera

Ameling

Wittfeld

d’Harcourt

Nauck

Völzke

, and others. 2019. Association of childhood traumatization and neuropsychiatric outcomes with altered plasma micro RNA-levels. Neuropsychopharmacology 44(12):2030–7.

200.

Verdú

Bercik

Verma-Gandhu

Huang

Blennerhassett

Jackson

, and others. 2006. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55(2):182–90.

201.

Vetulani

. 2013. Early maternal separation: a rodent model of depression and a prevailing human condition. Pharmacol Rep 65(6):1451–61.

202.

Von Korff

Dunn

. 2008. Chronic pain reconsidered. Pain 138(2):267–76.

203.

Walsh

McCartney

Smith

Armour

2019. Relationship between childhood socioeconomic position and adverse childhood experiences (ACEs): a systematic review. J Epidemiol Community Health 73(12):1087–93.

204.

Wang

Nie

Hou

Fan

, and others. 2014. Epigenetic upregulation of corticotrophin-releasing hormone mediates postnatal maternal separation-induced memory deficiency. PloS One 9(4):e94394.

205.

Wang

Jia

Song

, and others. 2018. The gut-microglia connection: implications for central nervous system diseases. Front Immunol 9:2325.

206.

Weaver

ICG

Cervoni

Champagne

D’Alessio

Sharma

Seckl

, and others. 2004. Epigenetic programming by maternal behavior. Nat Neurosci 7(8):847–54.

207.

Wiegand

Kreifelts

Munk

MHJ

Geiselhart

Ramadori

MacIsaac

, and others 2021. DNA methylation differences associated with social anxiety disorder and early life adversity. Transl Psychiatry 11:104.

208.

Willemen

Huo

Mao-Ying

Zijlstra

Heijnen

Kavelaars

2012. MicroRNA-124 as a novel treatment for persistent hyperalgesia. J Neuroinflammation 9(1):143.

209.

Wood

Patterson

Sunderland

Tainter

Glabus

Lilien

. 2007. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 8(1):51–8.

210.

World Health Organization. 2009. The physiological basis of breastfeeding. In: Infant and young child feeding: model chapter for textbooks for medical students and allied health professionals. Geneva (Switzerland): World Health Organization.

211.

World Health Organization. 2020. Adverse Childhood Experiences International Questionnaire (ACE-IQ) [accessed 24 Aug 2022]. https://www.who.int/publications/m/item/adverse-childhood-experiences-international-questionnaire-(ace-iq)

212.

World Health Organization. 2021. Violence against women [accessed 7 Feb 2023]. https://www.who.int/news-room/fact-sheets/detail/violence-against-women.

213.

World Health Organization. 2022. Child maltreatment [accessed 7 Feb 2023]. https://www.who.int/news-room/fact-sheets/detail/child-maltreatment.

214.

Sun

. 2006. Epigenetic regulation of stem cell differentiation. Pediatr Res 59(4):21–5.

215.

Zhang

2017. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet 18:517–34.

216.

Yang

Gelaye

Zhong

Rondon

Sanchez

Williams

. 2016. Serum brain-derived neurotrophic factor (BDNF) concentrations in pregnant women with post-traumatic stress disorder and comorbid depression. Arch Womens Ment Health 19(6):979–86.

217.

Yang

Seto

2007. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26(37):5310–8.

218.

Yehuda

Lehrner

2018. Intergenerational transmission of trauma effects: putative role of epigenetic mechanisms. World Psychiatry 17(3):243–57.

219.

Yin

Zhang

Liu

, and others. 2012. Insufficient maintenance DNA methylation is associated with abnormal embryonic development. BMC Med 10(1):26.

220.

Youssef

Gustin

Nash

Reeves

Petersen

Peck

, and others. 2014. Differential brain activity in subjects with painful trigeminal neuropathy and painful temporomandibular disorder. Pain 155(3):467–75.

221.

Zalar

Haslberger

Peterlin

2018. The role of microbiota in depression—a brief review. Psychiatr Danub 30:136–41.

222.

Zhang

Cai

Zou

Bie

Pan

. 2011. Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med 17(11):1448–55.

223.

Zhang

Gadotti

Chen

Souza

Stemkowski

Zamponi

. 2015. Role of prelimbic GABAergic circuits in sensory and emotional aspects of neuropathic pain. Cell Reports 12(5):752–9.

224.

Zhou

Hong

Cohen

Zhao

Schmidt

, and others. 2006. Brain-specific phosphorylation of MeCP2 regulates activity-dependent bdnf transcription, dendritic growth, and spine maturation. Neuron 52(2):255–69.

225.

Zhu

Cao

2019. Epigenetic programming and fetal metabolic programming. Front Endocrinol 10:764.

226.

Zupkovitz

Tischler

Posch

Sadzak

Ramsauer

Egger

, and others. 2006. Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol Cell Biol 26(21):7913–28.

Critical Windows: Exploring the Association Between Perinatal Trauma,Epigenetics,and Chronic Pain

Abstract

Keywords

Introduction

Epigenetic Regulation of Gene Expression

DNA Methylation

Histone Modifications

RNA Regulation

Epigenetic Regulation during Prenatal Neurodevelopment

Fetal Programming, Epigenetics, and the Maternal Environment

IPV during Pregnancy

Epigenetics and Early Life Neurodevelopment during Infancy

Adverse Childhood Experiences

An Overview of Chronic Pain and the Underlying Neuropathology

Prevalence and Epidemiology in Adolescence

Mesocorticolimbic System in Chronic Pain

A Complicated Relationship: Epigenetics, Trauma, and the Development of Chronic Pain

Prophylactic Treatments for Chronic Pain

Conclusion

Footnotes

Declaration of Conflicting Interests

Funding

ORCID iDs

References